Cargando…

Abstract 138: Efficacy of oral semaglutide according to race: An exploratory subgroup analysis of the PIONEER trial program

The global PIONEER program investigated the efficacy and safety of oral semaglutide, a glucagon-like peptide-1 receptor agonist. Patients with type 2 diabetes were randomized to once-daily oral semaglutide (3, 7 or 14 mg, or flexibly dosed [flex]), placebo, or active comparator (empagliflozin 25 mg,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srivastava, Kunal, Desouza, Cyrus, Amod, Aslam, Kallenbach, Klaus, Lin, Peter J, Nielsen, Morten Abildlund
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Abstracts … Esicon 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067771/ http://dx.doi.org/10.4103/2230-8210.342263

Ejemplares similares

Abstract 34: Time spent in glycemic control after initiating treatment with oral semaglutide versus empagliflozin: An exploratory analysis of the PIONEER 2 trial
por: Prakash, Prashanth S, et al.
Publicado: (2022)

Abstract 15: Glycemic and body weight responses to oral semaglutide in the PIONEER trial program
por: Kumar, K B Sharan, et al.
Publicado: (2022)

Abstract 25: Glycemic variability of oral semaglutide versus empagliflozin: A post hoc analysis of PIONEER 2
por: Shabeer, D, et al.
Publicado: (2022)

Abstract 10: Efficacy and safety of semaglutide 2.4 mg once- weekly in adults with overweight or obesity and type 2 diabetes (STEP 2)
por: Rahman, Syed Kasfur, et al.
Publicado: (2022)

Abstract 9: Once-weekly subcutaneous semaglutide 2.4 mg reduces body weight in adults with overweight or obesity regardless of baseline characteristics (STEP 1)
por: Suresh, Swaroop H, et al.
Publicado: (2022)

Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme
por: Aroda, Vanita R., et al.
Publicado: (2022)

Abstract 150: Whole exome sequencing of siblings identifies a novel variant p.A399fs in ANOS1 gene associated with Kallman syndrome
por: Sahlot, Rahul
Publicado: (2022)

Abstract 18: Circulating cell free long-noncoding RNA (PVT1 and MALAT1) expression in determining malignancy in indeterminate category of thyroid nodules
por: Dutta, Susmita, et al.
Publicado: (2022)

Abstract 135: A case of acquired Gitelman syndrome presenting as hypokalemic paralysis and AKI
por: Pradhan, Amrita
Publicado: (2022)

Abstract 43: Prevalence of islet-autoantibodies and monogenic diabetes in children with recent onset type 1 diabetes mellitus: A multicenter study
por: Jayakrishnan, C, et al.
Publicado: (2022)

Abstract 91: ACTH stimulated salivary cortisol is a better indicator of adrenal insufficiency compared to stimulated serum cortisol in subjects with cirrhosis liver
por: Karthik, V, et al.
Publicado: (2022)

Abstract 66: Spectrum of sleep abnormalities in primary hypothyroidism
por: Acharya, Himamshu, et al.
Publicado: (2022)

Abstract 29: Effect of gonadotropin releasing hormone analog treatment on final adult height in children with congenital adrenal hyperplasia complicated by central precocious puberty
por: Priyanka, R, et al.
Publicado: (2022)

Abstract 113: Impact of COVID-19 on arterial stiffness
por: Sahay, Rakesh Kumar, et al.
Publicado: (2022)

Abstract 46: Karyotype and phenotype correlation in Turner syndrome in South India
por: Raja, B Rameez, et al.
Publicado: (2022)

Abstract 26: To compare the efficacy and safety of 5 days a week levothyroxine verses daily replacement therapy in hypothyroid patients; experience from a tertiary care centre in Central India
por: Khare, Jaideep, et al.
Publicado: (2022)

Abstract 158: Comparison of different screening tools for predicting osteoporosis in community dwelling post-menopausal women
por: Singhal, Vaibhav, et al.
Publicado: (2022)

Abstract 117: Uncommon presentation of a common disease
por: Shruthi, B
Publicado: (2022)

Abstract 51: Clinical profile of hypertension and diabetes in elderly
Publicado: (2022)

Abstract 155: Vitamin D dependent rickets type II: Our experience and systematic review
por: Manjunath,
Publicado: (2022)

Abstract 83: Frax score does not accurately identify patients who need anti-osteoporotic treatment: A cross sectional study among elderly Indian men and postmenopausal women with a low trauma forearm fracture
por: Basheer, Shameer, et al.
Publicado: (2022)

Abstract 110: Prevalence of asymptomatic bacteriuria in patients with type 2 diabetes mellitus
por: Kolli, Sumanas Gopal Datta, et al.
Publicado: (2022)

Abstract 33: Clinical exome sequencing in XY DSD
por: Das, Debaditya, et al.
Publicado: (2022)

Abstract 70: High dose intravenous therapy augments complete anterior pituitary hormoanl recovery in primary autoimmune hypophysitis
por: Brijesh, K, et al.
Publicado: (2022)

Abstract 77: BMD, TBS and HSA in chronic glucocorticoid users attending a tertiary centre in Southern India
por: Hussain, Anwar
Publicado: (2022)

Abstract 69: A novel variant of MTHFR homozygous mutation causing hyperhomocystinemia in a case presenting as tall stature
por: Pande, Arunkumar R, et al.
Publicado: (2022)

Abstract 65: Effects of gender affirming hormone therapy on metabolic health and body composition in gender dysphoria
por: Kiran, Baratam Hari, et al.
Publicado: (2022)

Abstract 102: Case series of tumor induced osteomalacia
por: Mudalagiri, Manasa, et al.
Publicado: (2022)

Abstract 98: Hirsutism under evaluation
por: Harshita, B, et al.
Publicado: (2022)

Abstract 140: Significant reduction in HbA1c levels among participants with poorly controlled type 2 diabetes on diabefly(®) digital therapeutics program using multidisciplinary approach
por: Singal, Chitra Selvan Arbinder, et al.
Publicado: (2022)

Abstract 116: Clinical and biochemical predictors in early pregnancy for development of gestational diabetes mellitus
por: Manglunia, Ankit, et al.
Publicado: (2022)

Abstract 121: EFT in subclinical hypothyroidism and its correlation with various parameters
por: Sahu, Madhusmita, et al.
Publicado: (2022)

Abstract 84: Clinical and aetiological spectrum of thyrotoxic patients: A multi-centre analysis
por: Aggarwal, Ajay, et al.
Publicado: (2022)

Abstract 58: Favourable outcomes with therapeutic glucocorticoid regimen compared to replacement glucocorticoid regimen in primary hypophysitis
por: Das, Liza, et al.
Publicado: (2022)

Abstract 93: Ambulatory glucose profiles of children and adolescents with T1DM: Identification of factors affecting glycemic control
por: Tandon, Ambica, et al.
Publicado: (2022)

Abstract 133: Correlation of inflammatory markers with metabolic and hormonal parameters in first degree relatives of PCOS patients
por: Pradhan, J, et al.
Publicado: (2022)

Abstract 5: Similar hypoglycemia duration with once-weekly insulin icodec versus insulin glargine U100 in insulin naïve or experienced patients with T2D
por: Manjunath, Aparna, et al.
Publicado: (2022)

Abstract 56: Clinical profile of adult onset hypopituitarism in patients presenting to a tertiary care center in South Tamil Nadu
por: Jog, Komal, et al.
Publicado: (2022)

Abstract 120: Prevalence of hypogonadism in men with type 2 diabetes mellitus and its association with insulin resistance, metabolic and clinical parameters
por: Singh, Jaspreet, et al.
Publicado: (2022)

Abstract 37: Adolescent primary hyperparathyroidism masquerading as rickets
por: Mathew, Anu
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tlb2t4lms97mfsv4abtub71fsp